The IRF2BPL Knockout HAP1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population generated in the HAP1 human haploid cell line, designed to disrupt the IRF2BPL gene. This pooled knockout product provides a heterogeneous mixture of edited cells, enabling robust loss-of-function studies without clonal selection. The targeted gene disruption creates a model system for interrogating IRF2BPL function in a near-haploid genetic background, suitable for high-throughput genetic screens and systematic functional analyses.
The HAP1 host line is derived from the KBM-7 chronic myeloid leukemia cell line and exhibits a near-haploid karyotype in a male-origin background. This haploidy simplifies genetic manipulation, making HAP1 cells a preferred platform for CRISPR-based knockout screens, functional genomics, and arrayed library studies. The cells maintain stable growth characteristics and are well-characterized for genome-wide experimental approaches, providing a controlled environment for investigating gene regulatory networks.
IRF2BPL encodes a putative transcriptional regulator implicated in neuronal development and function. This protein is activated downstream of neuronal developmental signals and interacts with ataxin-1 and putative transcriptional co-repressors to modulate gene expression. It transcriptionally regulates a network of target genes involved in synaptic plasticity and neuronal survival, positioning IRF2BPL as a critical node linking extracellular signals to neuronal gene programs. Disruption of IRF2BPL leads to dysregulation of these targets, impairing synaptic function and contributing to neurodevelopmental pathologies.
In the HAP1 knockout context, loss of IRF2BPL provides a unique tool to dissect its transcriptional regulatory mechanisms in a simplified haploid system. Although HAP1 cells are non-neuronal, they express many core transcriptional components and can be utilized in reporter assays and ectopic expression studies to map IRF2BPL-dependent regulatory elements. This model thus bridges basic transcriptional biology and disease-relevant neuronal pathways, enabling identification of critical target genes and protein interactions.
This polyclonal knockout population is ideal for functional genomics applications, including transcriptome-wide RNA-seq, chromatin immunoprecipitation, and high-content phenotypic screens. It supports disease modeling for neurodevelopmental disorders such as NEDAMSS, drug discovery screening for small-molecule modulators of IRF2BPL pathways, and protein interaction studies with ataxin-1 using co-immunoprecipitation. Typical readouts include quantitative RT-qPCR, western blotting, immunofluorescence, and luciferase reporter assays, enabling detailed molecular phenotyping. For further information, please contact Ascent Research.
